Trastuzumab Rezetecan(SHR-A1811) Combined With Ivonescimab (AK112) in Locally Advanced or Metastatic Non-small Cell Lung Cancer Harboring HER2 Gene Abnormalities
PHASE2
This is a phase II trial in patients with locally advanced or metastatic no...
Status
Not Yet Recruiting
Location
Department of Medical Oncology,Cancer Center of Sun Yat-Sen University
A Study of Trastuzumab Rezetecan in Combination With Adebrelimab Versus Investigator's Choice of Therapy in Subjects With Residual Triple Negative Breast Cancer
PHASE3
It is a randomized, open label, positive drug controlled, multicenter desig...
Status
Not Yet Recruiting
Location
Cancer Hospital of Chinese Academy of Medical Sciences
Trastuzumab Rezetecan Followed by Pyrotinib, and Trastuzumab Combined With Capecitabine as First-line Treatment for Advanced HER2-positive Breast Cancer
PHASE2
This study is a single-arm, exploratory clinical trial, aiming to include p...